Indicated for: hypertension
Route of administration: oral
Substance: nimodipine (calcium channel blocker)
ATC: C08CA06 (Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives)
Nimodipine is a calcium channel blocker primarily used for the prevention and treatment of cerebral vasospasms associated with subarachnoid hemorrhage. It works by relaxing blood vessels in the brain, improving cerebral blood flow.
The medication is administered orally or intravenously, depending on the patient's condition. The dose and duration of treatment are determined by the physician based on the severity of the condition. Common side effects include dizziness, headaches, nausea, and low blood pressure.
Nimodipine is contraindicated in patients with hypersensitivity to the active substance or other calcium channel blockers. It should also be used with caution in patients with severe liver impairment.
This medication is essential for preventing severe neurological complications associated with subarachnoid hemorrhage, contributing to improved outcomes for affected patients.